Historical record - last NADAC publication: 10/24/2018
Product Information
NEULASTA 6 MG/0.6 ML SYRINGE is a brand product labeled by Amgen Inc., priced at $10074.8571 per ML under NDC 55513019001. Its NADAC has been published 308 times since Nov 28, 2013.
Strength
6 mg/.6mL
Manufacturer
Amgen Inc.NDC
55513019001
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
10/24/2018
Active Ingredients
PEGFILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA125031On Market Since
4/1/2002
Pharmacological Classes
Price Statistics
The NADAC for NEULASTA 6 MG/0.6 ML SYRINGE has been published 308 times since Nov 28, 2013, and over the history we have for it it has risen 53.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10074.8571 per ML |
|---|---|
| All-time high | $10074.8571 (Oct 16, 2019) |
| All-time low | $6583.2050 (Nov 28, 2013) |
| Median price | $8660.4531 |
| Average price | $8576.9784 |
| Largest weekly change | +5.6% (Mar 16, 2016) |
| Weeks tracked | 308 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEULASTA 6 MG/0.6 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for NEULASTA 6 MG/0.6 ML SYRINGE, manufactured by Amgen Inc., is $10074.8571 per ML (NDC 55513019001), effective Oct 16, 2019.
How has the price of NEULASTA 6 MG/0.6 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for NEULASTA 6 MG/0.6 ML SYRINGE has risen 53.0%. It has been tracked across 308 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEULASTA 6 MG/0.6 ML SYRINGE?
Since Nov 28, 2013, the NADAC for NEULASTA 6 MG/0.6 ML SYRINGE has ranged from a low of $6583.2050 (Nov 28, 2013) to a high of $10074.8571 (Oct 16, 2019), with a median of $8660.4531 per ML.
Are there cheaper alternatives to NEULASTA 6 MG/0.6 ML SYRINGE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, FULPHILA 6 MG/0.6 ML SYRINGE, is $3185.9367 per ML — about 68% below NEULASTA 6 MG/0.6 ML SYRINGE.
Who manufactures NEULASTA 6 MG/0.6 ML SYRINGE?
NEULASTA 6 MG/0.6 ML SYRINGE (NDC 55513019001) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification